Clinical Trial Update: A Study to Evaluate the Effect of IV Doses of Rivipansel in Subjects With Moderate Hepatic Impairment and in Healthy Subjects With Normal Hepatic Function [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating intravenous Rivipansel in subjects with moderate hepatic impairment and healthy controls with normal hepatic function has completed wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Impairment
• Normal Hepatic Function

Drugs mentioned

• Rivipansel (rivipansel)

Snippet

Sponsor: GlycoMimetics Incorporated | Conditions: Moderate Hepatic Impairment, Normal Hepatic Function | Phase 1 | Status: COMPLETED | Results posted: 2018-11-28